Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations

Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations

US Patent 7803569 · Granted Sep 28, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FX activation process and its use in the preparation of a FXa composition2025
Truncated von Willebrand factor polypeptides for extravascular administration in2024
Truncated von Willebrand Factor polypeptides for treating hemophilia2023
Methods for preparing modified von Willebrand Factor2023
Modified von Willebrand factor having improved half-life2021
Modulation of FVIII immunogenicity by truncated VWF2021
Methods for preparing modified von Willebrand factor2021
Methods for preparing modified von Willebrand factor2020
Truncated von Willebrand factor polypeptides for treating hemophilia2020
Sugar compositions for treating hemophilia A and/or Von Willebrand disease2019
Covalent complex of von Willebrand Factor and factor VIII, compositions, and use2018
Sugar compositions for treating hemophilia A and/or von Willebrand disease2017